This inventor holds 1 USPTO granted patent. Top assignee: Axxonis Pharma Ag. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Miroslav Flieger: Innovator in Migraine Treatment
Introduction
Miroslav Flieger is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of medicine, particularly in the treatment of migraines. His innovative approach has led to the development of a unique patent that addresses a common yet debilitating condition.
Latest Patents
Miroslav Flieger holds a patent for "Methods of using 1-allyl ergot alkaloid derivatives to treat migraines." This invention focuses on 1-allyl ergot alkaloids and their derivatives, which exhibit selective antagonistic properties to 5-HT receptors. The patent aims to provide prevention and relief from migraine-related headaches, Parkinson's disease, and disorders of thrombocyte function, among other applications. He has 1 patent to his name.
Career Highlights
Flieger is associated with Axxonis Pharma AG, a company dedicated to advancing pharmaceutical innovations. His work at Axxonis Pharma AG has allowed him to explore and develop new therapeutic methods that can significantly improve patient outcomes.
Collaborations
Throughout his career, Miroslav Flieger has collaborated with esteemed colleagues such as Sven Jaenichen and Heinz Pertz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Miroslav Flieger's contributions to migraine treatment through his innovative patent highlight his role as a key figure in medical advancements. His work continues to impact the lives of many individuals suffering from migraines and related disorders.